<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24951611</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1549-490X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>19</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The oncologist</Title>
<ISOAbbreviation>Oncologist</ISOAbbreviation>
</Journal>
<ArticleTitle>Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy.</ArticleTitle>
<Pagination>
<MedlinePgn>727-34</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1634/theoncologist.2013-0326</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Almost 500,000 women are newly diagnosed with cervical cancer (CC) every year, the majority from developing countries. There is little information on the survival of these patients. Our primary objective was to evaluate consecutive CC patients presenting over 4 years at the only radiotherapy center in Ethiopia.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">All patients with CC from September 2008 to September 2012 who received radiotherapy and/or surgery were included (without brachytherapy). Vital status was obtained through telephone contact or patient cards.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 2,300 CC patients, 1,059 patients with standardized treatment were included. At the end of the study, 249 patients had died; surviving patients had a median follow-up of 16.5 months; the 10% and 90% percentiles were 3.0 and 32.7 months, respectively. Mean age was 49 years (21-91 years). The majority of patients presented with International Federation of Gynecology and Obstetrics stage IIb-IIIa (46.7%). Because of progression during the waiting time (median 3.8 months), this proportion declined to 19.3% at the beginning of radiotherapy. The 1- and 2-year overall survival probabilities were 90.4% and 73.6%. If assuming a worst-case scenario (i.e., if all patients not available for follow-up after 6 months had died), the 2-year survival probability would be 45.4%.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study gives a thorough 4-year overview of treated patients with CC in Ethiopia. Given the limited treatment availability, a relatively high proportion of patients survived 2 years. More prevention and early detection at all levels of the health care system are needed. Increasing the capacity for external-beam radiation as well as options for brachytherapy would facilitate treatment with curative intention.</AbstractText>
<CopyrightInformation>Â©AlphaMed Press.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kantelhardt</LastName>
<ForeName>Eva Johanna</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA eva.kantelhardt@medizin.uni-halle.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moelle</LastName>
<ForeName>Ulrike</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Begoihn</LastName>
<ForeName>Matthias</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Addissie</LastName>
<ForeName>Adamu</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Trocchi</LastName>
<ForeName>Pietro</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yonas</LastName>
<ForeName>Bekuretsion</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hezkiel</LastName>
<ForeName>Petros</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stang</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thomssen</LastName>
<ForeName>Christoph</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vordermark</LastName>
<ForeName>Dirk</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gemechu</LastName>
<ForeName>Tufa</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gebrehiwot</LastName>
<ForeName>Yirgu</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wondemagegnehu</LastName>
<ForeName>Tigeneh</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aynalem</LastName>
<ForeName>Abreha</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mathewos</LastName>
<ForeName>Assefa</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany; School of Public Health, Departments of Pathology and Gynaecology, and Radiotherapy Center, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Oncologist</MedlineTA>
<NlmUniqueID>9607837</NlmUniqueID>
<ISSNLinking>1083-7159</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018572">Disease-Free Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D005002">Ethiopia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009367">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002583">Uterine Cervical Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Africa</Keyword>
<Keyword MajorTopicYN="N">Ethiopia</Keyword>
<Keyword MajorTopicYN="N">Prognosis</Keyword>
<Keyword MajorTopicYN="N">Survival</Keyword>
<Keyword MajorTopicYN="N">Uterine cervical neoplasms</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>6</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>6</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24951611</ArticleId>
<ArticleId IdType="pii">theoncologist.2013-0326</ArticleId>
<ArticleId IdType="doi">10.1634/theoncologist.2013-0326</ArticleId>
<ArticleId IdType="pmc">PMC4077439</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Lancet Oncol. 2010 Feb;11(2):165-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20005175</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Gynaecol Obstet. 2013 Mar;120(3):262-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23228820</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Oncol. 2008 Jul;9(7):683-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18598933</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Apr 2;360(14):1385-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19339719</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Breast Care (Basel). 2012 Apr;7(2):177-179</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22740807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):359-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10030262</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1434-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22806169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Oncol. 2012 Aug;13(8):790-801</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22658655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Gynaecol Obstet. 2009 May;105(2):107-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19342051</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cancer. 2010 Nov 15;127(10):2248-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20162609</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Equity Health. 2012;11:83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23273140</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>IARC Sci Publ. 2011;(162):243-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21675429</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull World Health Organ. 2013 Sep 1;91(9):697-703</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24101786</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Gynaecol Obstet. 2012 Dec;119(3):262-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22980432</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cancer. 2004 Mar 20;109(2):274-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14750180</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2012 Oct;41(5):1219-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23045194</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Oncol. 2013 Apr;14(4):e168-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23561748</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Oncol. 2008 Oct;9(10):929-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18805733</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer. 2012 Sep 15;118(18):4372-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22252462</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22237781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cancer. 2012 Nov 1;131(9):1969-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22623137</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2011 Oct 22;378(9801):1461-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21924486</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Gynaecol Obstet. 2012 Oct;119 Suppl 1:S80-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22884820</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Natl Cancer Inst. 2010 Oct 20;102(20):1557-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20884893</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cancer. 2013 Mar 1;132(5):1133-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22752881</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2010 May;7(5):e1000244</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20485489</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BJOG. 2010 Feb;117(3):348-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20015310</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>